SQUAWK/NEWS
Account
Account
Menu
Live NewsCategoriesequity

BeyondSpring Inc. (BYSI) News

Track canonical SquawkNews coverage tagged to BYSI, BeyondSpring Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol BYSI Asset equity Sector Markets 90 days 1 Last 0.85 Updated Aug 13, 2026, 03:50 PM UTC Open live news feed
M BYSI unit SEED Therapeutics gets FDA orphan drug designation for ST-01156 BeyondSpring’s subsidiary SEED Therapeutics receives FDA orphan drug designation for ST-01156, a small molecule degrader of RNA-binding motif protein 39, for neuroblastoma. REGULATION | Aug 13, 2026, 03:50 PM UTC